BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register
Portfolio (Quarterly) Guide ↗

Boxer Capital Management, LLC

· CIK 0002018299
13F Portfolio $199M AUM 20 positions Filed Feb 17, 2026 EDGAR ↗ ← All Funds
Q3 2025 Q2 2025 · All 20 New
# Ticker Company Sector Shares Value ↓ % Port Chg Shares Chg % Period Price ① Since Period ①
1 TNGX TANGO THERAPEUTICS INC Healthcare 9,771,485.0 $50.0M 25.18% NEW — $5.12 +386.7%
2 RVMD REVOLUTION MEDICINES INC Healthcare 792,977.0 $29.2M 14.69% NEW — $36.79 +457.1%
3 REPL REPLIMUNE GROUP INC Healthcare 2,211,341.0 $20.5M 10.34% NEW — $9.29 +33.0%
4 — MERUS N V — 365,000.0 $19.2M 9.66% NEW — $52.60 —
5 KYMR KYMERA THERAPEUTICS INC Healthcare 432,010.0 $18.9M 9.49% NEW — $43.64 +156.5%
6 QURE UNIQURE NV Healthcare 899,500.0 $12.5M 6.31% NEW — $13.94 +174.2%
7 — ITEOS THERAPEUTICS INC — 825,000.0 $8.2M 4.14% NEW — $9.97 —
8 URGN UROGEN PHARMA LTD Healthcare 575,000.0 $7.9M 3.96% NEW — $13.70 +201.8%
9 AMLX AMYLYX PHARMACEUTICALS INC Healthcare 1,225,000.0 $7.9M 3.95% NEW — $6.41 +360.1%
10 — CRESCENT BIOPHARMA INC. — 453,686.0 $7.3M 3.69% NEW — $16.14 —
11 PTGX PROTAGONIST THERAPEUTICS INC Healthcare 60,000.0 $3.3M 1.67% NEW — $55.27 +156.7%
12 NKTR NEKTAR THERAPEUTICS Healthcare 125,000.0 $3.2M 1.63% NEW — $25.84 +120.8%
13 KOD KODIAK SCIENCES INC Healthcare 750,000.0 $2.8M 1.41% NEW — $3.73 +767.3%
14 — CIDARA THERAPEUTICS INC — 55,000.0 $2.7M 1.35% NEW — $48.71 —
15 NRIX NURIX THERAPEUTICS INC Healthcare 175,000.0 $2.0M 1.00% NEW — $11.39 +102.0%
16 — INSTIL BIO INC — 70,700.0 $1.5M 0.74% NEW — $20.83 —
17 KALV KALVISTA PHARMACEUTICALS INC Healthcare 93,400.0 $1.1M 0.53% NEW — $11.30 +138.8%
18 SRPT SAREPTA THERAPEUTICS INC Healthcare 25,000.0 $428K 0.21% NEW — $17.10 +9.2%
19 — NUVATION BIO INC — 266,666.0 $72K 0.04% NEW — $0.27 —
20 — SURROZEN INC — 66,666.0 $1K 0.00% NEW — $0.02 —

① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.

Sector Allocation
Healthcare 100.0%